Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39076563

Authors

Bharat Sidhu

Akash Mavilakandy

Katherine L Hull

Ivelin Koev

Zakariyya Vali

James O Burton

G Andre Ng

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) and atrial fibrillation (AF) are associated with significant cardiovascular morbidity and mortality. Recent studies have highlighted an increased prevalence and incidence of AF in patients with CKD. This article aims to provide a comprehensive review of current management strategies and considerations of treating atrial fibrillation with concomitant CKD. Potential electrophysiological mechanisms between AF and CKD are explored. Current evidence and literature focusing on pharmacological rate and rhythm control along with procedural intervention is reviewed and presented. The management of AF and CKD together is complex, but particularly pertinent when considering the close cyclical relationship in the progression of both diseases.

References

Kallergis E, Manios E, Kanoupakis E, Mavrakis H, Arfanakis D, Maliaraki N . Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. J Am Coll Cardiol. 2008; 52(3):211-5. DOI: 10.1016/j.jacc.2008.03.045. View

Vazquez E, Sanchez-Perales C, Lozano C, Garcia-Cortes M, Borrego F, Guzman M . Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol. 2003; 92(7):868-71. DOI: 10.1016/s0002-9149(03)00904-4. View

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38):2893-2962. DOI: 10.1093/eurheartj/ehw210. View

Soliman E, Prineas R, Go A, Xie D, Lash J, Rahman M . Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010; 159(6):1102-7. PMC: 2891979. DOI: 10.1016/j.ahj.2010.03.027. View

Siontis K, Zhang X, Eckard A, Bhave N, Schaubel D, He K . Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States. Circulation. 2018; 138(15):1519-1529. PMC: 6202193. DOI: 10.1161/CIRCULATIONAHA.118.035418. View

Sairaku A, Yoshida Y, Kamiya H, Tatematsu Y, Nanasato M, Hirayama H . Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis. J Cardiovasc Electrophysiol. 2012; 23(12):1289-94. DOI: 10.1111/j.1540-8167.2012.02422.x. View

Khouri Y, Stephens T, Ayuba G, AlAmeri H, Juratli N, McCullough P . Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease. J Atr Fibrillation. 2016; 7(6):1069. PMC: 4956356. DOI: 10.4022/jafib.1069. View

Lip G, Banerjee A, Boriani G, Chiang C, Fargo R, Freedman B . Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest. 2018; 154(5):1121-1201. DOI: 10.1016/j.chest.2018.07.040. View

Turakhia M, Blankestijn P, Carrero J, Clase C, Deo R, Herzog C . Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018; 39(24):2314-2325. PMC: 6012907. DOI: 10.1093/eurheartj/ehy060. View

10.

Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A . Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018; 33(suppl_3):iii28-iii34. PMC: 6168816. DOI: 10.1093/ndt/gfy174. View

11.

Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M . Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999; 354(9176):359-64. DOI: 10.1016/S0140-6736(98)10363-X. View

12.

Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H . Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm. 2010; 8(3):335-41. DOI: 10.1016/j.hrthm.2010.10.047. View

13.

Kiuchi M . Atrial fibrillation and chronic kidney disease: A bad combination. Kidney Res Clin Pract. 2018; 37(2):103-105. PMC: 6027811. DOI: 10.23876/j.krcp.2018.37.2.103. View

14.

Metivier F, Marchais S, Guerin A, Pannier B, London G . Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000; 15 Suppl 3:14-8. DOI: 10.1093/oxfordjournals.ndt.a027970. View

15.

Verma A, Cairns J, Mitchell L, Macle L, Stiell I, Gladstone D . 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014; 30(10):1114-30. DOI: 10.1016/j.cjca.2014.08.001. View

16.

Chokesuwattanaskul R, Thongprayoon C, Tanawuttiwat T, Kaewput W, Pachariyanon P, Cheungpasitporn W . Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis. Pacing Clin Electrophysiol. 2018; 41(6):627-634. DOI: 10.1111/pace.13331. View

17.

Roden D, Woosley R . Drug therapy. Flecainide. N Engl J Med. 1986; 315(1):36-41. DOI: 10.1056/NEJM198607033150106. View

18.

Li M, Liu T, Luo D, Li G . Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation. Cardiol J. 2013; 21(1):89-95. DOI: 10.5603/CJ.a2013.0116. View

19.

Ravelli F, Allessie M . Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997; 96(5):1686-95. DOI: 10.1161/01.cir.96.5.1686. View

20.

January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J . 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the.... J Am Coll Cardiol. 2019; 74(1):104-132. DOI: 10.1016/j.jacc.2019.01.011. View